The Valley Desk

NCT06769698 · Interventional trial

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Overall registry status Recruiting

Phase 2

Conditions Head and Neck Squamous Cell Carcinoma (HNSCC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov